CompletedPhase 2NCT00779454

Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vejle Hospital
Principal Investigator
Anders Jakobsen, DMSc
Vejle Hospital, Vejle, Denmark
Intervention
Gemcitabine, Oxaliplatin, Capecitabine,(drug)
Enrollment
72 enrolled
Eligibility
18-80 years · All sexes
Timeline
20082016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00779454 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma

← Back to all trials